U.S. Chemicals Stock News

Cummins (CMI) has drawn fresh attention after its Power Generation business was selected to supply battery energy storage systems for a large U.S. data center project focused on managing AI-driven power demand. See our latest analysis for Cummins. Despite the BESS announcement, Cummins’ share price has pulled back, with the 7 day share price return down 8.34% and the 30 day share price return down 11.58%. However, the 1 year total shareholder return of 50.54% points to momentum that has built...

Lennox International: Why Efficiency Metrics Are Back in Focus Fresh attention on Lennox International (LII) has been triggered by recent commentary highlighting its operating margin, free cash flow margin, and return on capital, which together are drawing closer scrutiny from investors. See our latest analysis for Lennox International. Lennox International's recent share price has come under pressure, with the 30 day share price return down 25.55% and the year to date share price return down...

ImmunityBio, Inc. recently appointed former World Bank president Dr. Jim Yong Kim as Vice Chairman, placing him in a newly created Office of the Executive Chairman to focus on global relationships with governments, health ministries, multilateral institutions, and other health partners. This move brings deep global health and development expertise directly into ImmunityBio’s leadership, potentially reshaping how the company pursues international access to its immunotherapy platform and...

With Treasury yields high, inflation still above 3% and the Federal Reserve’s next steps under close watch at Jackson Hole, investors are again questioning how much risk they really want to take. That uncertainty is pushing more attention toward high quality dividend stocks in defensive sectors that may handle prolonged higher rates differently. This article reveals three stocks exposed to these macro shifts and explains why each one could deserve a closer look right now. The stocks covered...

Alnylam Pharmaceuticals has had a difficult run over the past year, with the share price down 46.8%, while the current valuation checks still lean toward the stock being on the expensive side rather than a clear bargain. Over the past 12 months, Alnylam Pharmaceuticals shareholders have seen the stock decline 46.8%, which puts a spotlight on whether earlier optimism was too strong. Upcoming clinical data on RNAi programs like the transthyretin and hypertension studies can support sentiment...

In August 2026, Mattel announced a 3,509-piece, 1:1-scale buildable model of the original Microsoft XBOX under its Mattel Brick Shop premium brand, alongside new UNO Championship Series products that turn the classic card game into a competitive, tournament-style experience for home play. By pairing an adult-focused, high-end gaming collectible with a refreshed competitive format for one of its best-known family games, Mattel is broadening its reach across gamers, collectors, and large-group...

UMB Financial (UMBF) reported a strong second quarter, with revenue and earnings above expectations, supported by loan growth, solid asset quality, and higher fee income from monetizing investments. Despite this, the stock price reaction remained muted. See our latest analysis for UMB Financial. At a share price of US$145.14, UMB Financial has delivered a 24.61% year to date share price return. The 1 year total shareholder return of 22.10% and the very strong 3 year total shareholder return...

Ascendis Pharma earnings event and why it matters for shareholders Ascendis Pharma (NasdaqGS:ASND) recently reported second quarter 2026 results, with sales of €339.29 million and net income of €206.97 million, following a net loss in the same period a year earlier. See our latest analysis for Ascendis Pharma. Following the strong second quarter earnings shift into profitability, Ascendis Pharma's 7 day share price return of 2.38% and 90 day share price return of 5.69% suggest momentum has...

Leidos Holdings (LDOS) has secured a new five year, US$301 million contract to monitor U.S. military networks around the clock. The work extends its role in cyber defense for the Department of War. See our latest analysis for Leidos Holdings. At a share price of US$141.39, Leidos Holdings has seen a 30 day share price return of 26.08% and a 90 day share price return of 10.36%, while the 1 year total shareholder return is down 21.33% but up just over 50% across three and five years. This...

DoorDash (DASH) has been in focus after new partnerships with Barnes & Noble, Carter's, Kohl's, and Gap expanded its Marketplace into books, apparel, and broader back to school essentials for same day delivery. See our latest analysis for DoorDash. The latest partnerships come as DoorDash’s share price has gained momentum, with a 30 day share price return of 29.25% and a 90 day share price return of 45.12%, even though the 1 year total shareholder return declined 8.88% while the 3 year total...

Recent trading snapshot and return profile Essent Group (ESNT) recently closed at US$68.07, with the stock down about 0.7% on the day and 2% over the past week, yet up in the past month and past 3 months. For longer term holders, Essent Group shows a 10.4% total return over the past year, with multi year total returns above 40% over 3 years and above 60% over 5 years. See our latest analysis for Essent Group. For context, Essent Group’s short term share price momentum has cooled slightly...

Chipotle Mexican Grill (CMG) is drawing investor attention after announcing its first restaurant in Saudi Arabia later this month, in partnership with Alshaya Group. The move extends a growing presence across the Middle East. See our latest analysis for Chipotle Mexican Grill. The Saudi Arabia opening comes after a period of solid short term momentum for Chipotle Mexican Grill, with a 1 month share price return of 16.07% and a 90 day share price return of 14.21%, even as the 1 year total...

Visa stock has delivered a strong 66.7% return over the past 5 years, yet current checks suggest it no longer looks clearly cheap. The intrinsic value estimate from the Excess Returns model is broadly in line with the market price, while earnings-based multiples lean expensive. Recent news around antitrust litigation and new payment initiatives means investors are weighing solid past gains against what they are now paying for Visa’s future cash flows. A 66.7% gain over 5 years frames Visa as...

Neurocrine Biosciences stock has delivered a 59.0% return over the past five years, yet its current valuation checks still lean on the cheap side rather than pricing in a clear premium. That mix of solid long term performance and a strong value read is what investors now need to weigh. Over the past 5 years, Neurocrine Biosciences has returned 59.0%, which puts recent share price moves in the context of a stock that has already created meaningful value for long term holders. Fresh data from...

Dividend affirmation sets the stage for Pathward Financial stock discussion Pathward Financial (CASH) has affirmed a quarterly cash dividend of $0.05 per share for its fourth fiscal quarter of 2026, payable on October 1 to shareholders of record on September 10. See our latest analysis for Pathward Financial. Alongside the dividend affirmation, Pathward Financial’s recent trading has been steady rather than sharp, with the share price at US$83.68 and a year to date share price return of...

Moderna stock has surged over the past year, yet the company currently screens as expensive on Simply Wall St's broader valuation checks. This raises questions about how much of the good news is already reflected in the share price. Moderna has returned 472.5% over the past year, which puts recent optimism at the center of any discussion about what investors are now paying for future cash flows. The recent positive Phase 3 melanoma vaccine results can support higher long term growth...

Recent commentary around Whirlpool (WHR) has focused on declining revenue, weaker earnings, and a relatively high net-debt-to-EBITDA ratio. Together, these factors are raising fresh investor concerns as customers delay major appliance purchases. See our latest analysis for Whirlpool. Whirlpool’s share price has recently shown a short burst of strength, with a 1-month share price return of 8.26% and a 7-day gain of 1.92%. However, this follows a much steeper reset that leaves the year-to-date...

On 17 August 2026, Sunrun Inc. announced an agreement with Voltus Inc. to supply energy capacity from its residential solar-plus-storage fleet in the PJM and MISO regions to support Voltus’s Bring Your Own Capacity programs for AI hyperscalers. The collaboration highlights how Sunrun is turning thousands of home batteries and smart devices into a virtual power resource that can earn payments for participants while supporting data-center-driven grid demand. Next, we’ll examine how channeling...

Earlier this month, Realty Income Corporation declared its 674th consecutive monthly common stock dividend of US$0.2710 per share, annualized at US$3.252, payable on September 15, 2026 to stockholders of record as of August 31, 2026. Away from its long-running income payouts, Realty Income has also completed and announced sizeable convertible senior note offerings due 2031, reshaping its funding mix and adding a new layer of capital structure complexity for investors to assess. We’ll now...

STERIS (STE) stock has recently drawn attention after its latest share price move, with the company closing at $237.93 on 19 August 2026. Investors are weighing this valuation against its recent performance and financial profile. See our latest analysis for STERIS. Over the past month STERIS has seen an 11.15% 1 month share price return and a 10.02% 3 month share price return, although the year to date share price return is down 4.84% and the 1 year total shareholder return is down 3.23%...

Warrior Met Coal stock has delivered a very strong 442.3% return over the past 5 years, while the current valuation checks send a mixed message with a low overall value score but an intrinsic value estimate from a Discounted Cash Flow (DCF) suggesting the shares trade at a sizeable discount to that estimate. The 442.3% 5 year return shows Warrior Met Coal has already rewarded long term holders in a big way. Ramping production at the low cost Blue Creek mine can support cash flow, although...

NIKE stock is coming off a steep multi year slide, with the share price down about 73.7% over 5 years, while current valuation checks paint a mixed picture that includes a fairly valued intrinsic estimate and an undervalued signal on earnings multiples. The roughly 73.7% share price decline over 5 years suggests investors have sharply reset expectations for NIKE. Recent coverage of NIKE's turnaround efforts and wholesale reset may support a case for earnings and cash flow improvement, while...

Arbor Realty Trust (NYSE:ABR) completed an $825 million commercial real estate mortgage loan securitization, retaining a meaningful portion of subordinated interests. The transaction includes a multi-year reinvestment period that allows principal proceeds to be used for new loans. Arbor Realty Trust plans to use securitization proceeds for both deleveraging and funding future lending activity. The deal affects the company’s funding mix, risk profile and liquidity at a time when financing...

Medtronic (MDT) affirmed its shareholder return policy on 20 August 2026, as the board approved a second quarter fiscal 2027 cash dividend of $0.72 per ordinary share, payable on 16 October 2026. See our latest analysis for Medtronic. Medtronic’s latest dividend affirmation comes after a period of stronger short term share price momentum, with a 90 day share price return of 20.3% and a 30 day gain of 12.19%. Over the same time frame, the 1 year total shareholder return of 4.72% and 3 year...